NEW YORK, May 1 (Reuters) - Purdue Pharma said on Friday that it has ceased operations and concluded its bankruptcy, re-emerging as a nonprofit focused on treating opioid addiction, overseen by a new ...
This article was produced for ProPublica’s Local Reporting Network in partnership with The Philadelphia Inquirer. Sign up for Dispatches to get our stories in your inbox every week. Mary Jannotta ...
Purdue Pharma, the bankrupted drug manufacturer at the center of the nation’s yearslong opioid epidemic, shut down May 1. The closure is part of a $7.4 billion deal reached after Purdue and the ...
Purdue Pharma, the controversial maker of the prescription opioid OxyContin, is set to move forward this week with its plan to shut down and be replaced by a new company. The Stamford-based firm ...
EDITOR’S NOTE: This story was originally published by ProPublica, a nonprofit newsroom that investigates abuses of power. It was produced for ProPublica’s Local Reporting Network in partnership with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results